Observational study on cluster headaches and trigeminal neuralgia
Official title: The Will Erwin Headache Research Center Study of Cluster Headache and Trigeminal Neuralgia
Run by The University of Texas Health Science Center, Houston · NCT02910323 · Data updated 2026-11-12
This study is trying to learn more about cluster headaches and trigeminal neuralgia by gathering information from patients to help match them for future treatments.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | The University of Texas Health Science Center, Houston Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | July 12, 2016 |
| Main results expected | December 2035 |
| Study ends | December 2035 |
| Registry record updated | February 18, 2026 |
| Trial ID | NCT02910323 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals diagnosed with trigeminal autonomic cephalalgias or trigeminal neuralgia as per the International Headache Classification.
✕Probably not a fit
Patients with a life expectancy of less than one year or those with conditions that hinder appropriate diagnosis will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Will Erwin Headache Research Center is creating a national registry for patients with Cluster Headache and Trigeminal Neuralgia. This observational study will categorize participants based on various characteristics such as type and severity of their condition, associated symptoms, and psychological factors. Detailed evaluations will include genomic studies, medical history, imaging reports, and physical exams. The goal is to better understand these conditions and facilitate patient matching for future interventional clinical trials.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of cluster headaches and trigeminal neuralgia.
How similar studies have gone: Other studies have shown promise in understanding trigeminal autonomic cephalalgias, but this specific observational approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of a trigeminal autonomic cephalalgia according to the International Headache Classification including episodic cluster headache, chronic cluster headache, episodic paroxysmal hemicrania, chronic paroxysmal hemicrania, episodic short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT), chronic SUNCT, episodic short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA), chronic SUNA, and hemicrania continua. OR Diagnosis of a trigeminal neuralgia according to the International Headache Classification, including classical trigeminal neuralgia and symptomatic trigeminal neuralgia. * Able to provide HIPAA authorization to share prior medical records/imaging. Exclusion Criteria: * Life expectancy less than 1 year, co-existing disease or other characteristic that precludes appropriate diagnosis of a trigeminal autonomic cephalalgia or trigeminal neuralgia. * Active drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements * Inability or unwillingness of subject or legal guardian/representative to give informed consent. Inclusion Criteria for Healthy Volunteers: * Inclusion criteria is willingness to consent and be of age 18 and older
Where it's running
-
The University of Texas Health Science Center at Houston
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Mark Burish, MD, PhD — The University of Texas Health Science Center, Houston
- Study coordinator: Rebecca Martinez, RN
- Email: nctt.wec@uth.tmc.edu
- Phone: 713-486-7771
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
A real-world look at trigeminal autonomic cephalalgias in Italy
This study follows adults with TACs like cluster headache and related conditions in routine care to see how treatments work and what factors influence outcomes over time.
-
Endoscopic injection of Exparel for craniofacial pain relief
This study is testing if an injection of Exparel can help people with craniofacial pain, like migraines and cluster headaches, feel better compared to a placebo.
-
Magnesium sulfate for acute non-traumatic headache in the ED: 2 g vs 4 g vs standard paracetamol
This study tests whether intravenous magnesium sulfate given in different doses helps adults with acute non-traumatic headache in the emergency department, compared with paracetamol.
-
RP-008 with daily varenicline for trigeminal neuralgia
A new treatment approach tests RP-008 together with varenicline to see if it is safe, tolerable, and offers pain relief for adults with trigeminal neuralgia.
-
Yoga-based Movements for Primary Headaches (YOURHEAD)
A yoga-based movement program is being tested to see if it can help reduce headaches and improve quality of life for adults with migraine and/or cluster headaches.
-
Using intravenous lacosamide to treat acute pain in trigeminal neuralgia
This study is testing if intravenous lacosamide can help relieve severe facial pain in people with trigeminal neuralgia who come to the emergency room.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.